OctreoScan: Difference between revisions

Jump to navigation Jump to search
(New page: right|300px ==Indications for imaging== *Tumor evaluation (i.e. Pheochromocytoma , Paraganglioma , Islet cell tumor , Carcinoid , [[Me...)
 
No edit summary
Line 3: Line 3:
==Indications for imaging==
==Indications for imaging==


*Tumor evaluation (i.e. [[Pheochromocytoma]] , [[Paraganglioma]] , [[Islet cell tumor]] , [[Carcinoid]] , [[Medullary carcinoma of thyroid]] , [[Small cell lung cancer]] , [[Neuroblastoma]] , [[Pituitary adenoma]] , [[Lymphoma]] , [[Breast cancer]] , [[Astrocytoma]] , [[Meningioma]] , [[Thymoma]] ).
* Tumor evaluation  
 
:* [[Pheochromocytoma]]
:* [[Paraganglioma]]
:* [[Islet cell tumor]]
:* [[Carcinoid]]
:* [[Medullary carcinoma of thyroid]]
:* [[Small cell lung cancer]]
:* [[Neuroblastoma]]
:* [[Pituitary adenoma]]
:* [[Lymphoma]]
:* [[Breast cancer]]
:* [[Astrocytoma]]
:* [[Meningioma]]  
:* [[Thymoma]]  


==Patient preparation==  
==Patient preparation==  


*Bowel preparation with laxative and enema
* Bowel preparation with laxative and enema
*Discontinue octeotide therapy for 1 week prior the exam
* Discontinue octeotide therapy for 1 week prior the exam


==Radiopharmaceutical==
==Radiopharmaceutical==

Revision as of 16:53, 26 February 2009

Indications for imaging

  • Tumor evaluation

Patient preparation

  • Bowel preparation with laxative and enema
  • Discontinue octeotide therapy for 1 week prior the exam

Radiopharmaceutical

  • In-111 OctreoScan

Dose and route of administration

  • 6 mCi IV
    • 4 hours (abdomen, pelvis)
    • 24 hours (whole body)

Equipment

  • Camera: Large field of view SPECT gamma camera
  • Collimator: Medium-energy
  • Window: 20% window around 173 and 245 KeV

Procedure

  • 4 hours: Planar images of the abdomen and pelvis
  • 24 hours: Planar images of the whole body. SPECT of regions of clinical concern.

Images

Normal OctreoScan

References